Effect of acute and long-term treatment with 17-/?-estradiol on the vasomotor responses in the rat aorta

British Journal of Pharmacology

Volumn 126, Issue 1, 1999, Pages 159-168

  Andersen, Heidi L ^a   Weis, Jan U ^a   Fjalland, Bjarne ^a   Korsgaard, Niels ^a  

^a NOVO NORDISK A S   (Denmark)

Author keywords

17 estradiol; Acute; Aorta; Calcium; Long term; Nitric oxide; Rat; Vasomotor response

Indexed keywords

ACETYLCHOLINE; CALCIUM; ESTRADIOL BENZOATE; NITRIC OXIDE; PHENYLEPHRINE; POTASSIUM; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTERY CONSTRICTION; ARTERY DILATATION; ARTERY TONE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; FEMALE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; VASCULAR ENDOTHELIUM; VASOMOTOR REFLEX;

ACETYLCHOLINE; ANIMALS; AORTA, THORACIC; CALCIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; ESTRADIOL; FEMALE; FREE RADICAL SCAVENGERS; MUSCLE CONTRACTION; MUSCLE RELAXATION; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PHENYLEPHRINE; POTASSIUM; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; TIME FACTORS; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS; VASOMOTOR SYSTEM;

EID: 0032894530     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702289     Document Type: Article

References (68)

1. ABEBE, W. & AGRAWAL, O.K. (1995). Role of tyrosine kinases in norepinephrine-induced contraction of vascular smooth muscle. J. Cardiovas. Pharmacol., 26, 153-159.
2. ADAMS, M.R., KAPLAN, J.R., MANUCK, S.B., KORITNIK, D.R., PARKS, J.S., WOLF, M.S. & CLARKSON, T.B. (1990). Inhibition of coronary artery atherosclerosis by 17-estradiol in ovariectomized monkeys. Athersclerosis, 10, 1051-1057.
3. BABAI, H., EVANS, T., IRVING, G. & McCURRIE, J.R. (1995). Calcium-independence of the relaxant effect of oestrogens on isolated rat aorta. Br. J. Pharmacol., 11, 402.
4. BARRET-CONNER, E. & BUSH, T.L. (1991). Estrogen and coronary heart diseases in women. JAMA, 26, 1861 -1867.
5. BAYARD, F., CLAMENS, S., MEGGETTO, F., BLAES, N., DELSOL, G. & PAYE, J.C. (1995). Estrogen synthesis, estrogen metabolism, and functional estrogen receptors in rat arterial smooth muscle cells in culture. Endocrinology. 13, 1523-1529.
6. BENTO, A.C. & DE MORAES, S. (1992). Effects of estrogen pretreatment of the spare alpha 1-adrenoceptors and the slow and fast components of the contractile response of the isolated female rat aorta. Gen. Pharmacol., 23, 565-570.
7. BUSH, T.L., BARRET-CONNOR, E., COWAN, L.D., CRIQUI, M.H., WALLACE, R.B., SUCHINDRAN, C.M., TYROLER, H.A. & RIFKIND, B.M. (1987). Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation. 75, 1102-1109.
8. CHESTER, A.H., Jiang, C, BORLAND, J.A., YACOUB, M.H. & COLLINS, P. (1995). Oestrogen relaxes human epicardial coronary arteries through non-endothelium-dependent mechanisms. Coron. Artery. Dis., 6, 417-422.
9. COLLINS, P., ROSANO, G.M., JIANG, C, L1NDSAY, D., SARREL, P.M. & POOLE-WILSON, P.A. (1993). Cardiovascular protection by oestrogen-a calcium antagonist effect? Lancet, 34, 1264-1265.
10. COLLINS, P., ROSANO, G.M., SARREL, P.M., ULRICH, L., ADAMOPOULOS, S., BEALE, C.M., MCNEILL, J.G. & POOLE-WILSON, P.A. (1995). 17-beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation, 92, 24-30.
11. COLLUCCI, W.S., GIMBRONE, M.A., MACLAUGHILN, M.K., HALPERN, W. & ALEXANDER, R.W. (1982). Increased vascular catecholamine sensitivity and a-adrenergic receptor affinity in female and estrogen treated male rats. Circ. Res., 50, 805-811.
12. EZIMOK.HAI, M., ALOAMAKA, C.P., CHERIAN, T. & MORRISON, J. (1994). The role of extracellular calcium in pregnancy-induced attenuation of Phenylephrine contraction in rat aorta with functional endothelium. J. Comp. Physio!. Biochem. Sys. Enviro. Physiol., 16,81-87.
13. FURCHGOTT, R.F. & VANHOUTTE, P.M. (1989). Endotheliumderived relaxation and contracting factors. FASEB J., 3, 200720018.
14. FURCHGOTT, R.F. & ZAWADZKI, J.V. (1980). The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 28, 373-376.
15. GILLIGAN, D.M., QUYYUMI, A.A. & CANNON, R.O. (1994). Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation, 89, 2545-2551:
16. GISCLARD, V., MILLER, V.M. & VANHOUTTE, P.M. (1988). Effect of 17 beta-estradiol on endothelium-dependent responses in the rabbit. J. Pharmacol. Exp. Tlier., 24, 19-22.
17. GRIFFITH, J.C., HENDERSON, A.H., HUGHES, D. & LEWIS, M.J. (1984). Isolated perfused coronary artery and aortic strip preparations: the role of endothelium-derived relaxant factor. J.Physiol..3Sl, 13-24.
18. 2+ release induced by thromboxane A2 in porcine coronary artery. Circulation, 91, 2619-2626.
19. HAYASHI, T., YAMADA, K., ESAK.I, T., KUZUYA, M., SATAKE, S., ISHIKAWA, T., HIDAKA, H. & IGUCHI, A. (1995). Estrogen increases endothelial nitric oxide by a receptor-mediated system. Biochem. Biophys. Res. Com., 21, 847-855.
20. HAYASHI, T., YAMADA, K., ESAKI, T., MUTOH, E. & IGUCHI, A. (1997). Effect of estrogen on isoforms of nitric oxide synthase: possible mechanism of anti-atherosclerotic effect of estrogen. Gerontology, 43, 124- 134.
21. HERRINGTON, D.M., BRADEN, G.A., WILLIAMS, J.K. & MORGAN, T.M. (1994). Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy. Am. J. Cardiol., 73, 951-952.
22. HISHIKAWA, K., NAKAKI, T., MARUMO, T., SUZUKI, H., KATO, R. & SARUTA, T. (1995). Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells. FEES Lett., 36, 291-293.
23. HOLM, P., ANDERSEN, H.O., NORDESTGAARD, B.C., HANSEN, B.F., KJELDSEN, K. & STENDER, S. (1995). Effect of oestrogen replacement therapy on development of experimental arteriosclerosis: a study in transplanted and balloon-injured rabbit aortas. Atherosclerosis, 11, 191-200.
24. HOLM, P., KORSGAARD, N., SHALMI, M., ANDERSEN, H.L., HOUGAARD, P., SKOUBY, S.O. & STENDER, S. (1997). Significant reduction of the anti-atherogenic effect of estrogen by long-term inhibition of nitric oxide synthesis in cholesterol-clamped rabbits. J. Clin. Invest.. 10, 821-828.
25. HONDA, H., KANEKO, H., KONDO, M. & KOGO, H. (1996). Comparison of endothelium-derived relaxing factor activity between nonpregnant and pregnant rats. Comp. Biochem. Physiol. Pharmacol. Toxicol. Endocrinol., 114, 193-196.
26. HUANG, A., SUN, D., KOLLER, A. & KALEY, G. (1997). Gender difference in the myogenic tone of rat arterioles is due to estrogen-induced, enhanced release of NO. Am. J. Physiol., 27, H1804-H1809.
27. JIANG, C.W., SARREL, P.M., LINDSAY, D.C., POOLE-WILSON, P.A. & COLLINS, P. (1991). Endothelium-independent relaxation of rabbit coronary artery by 17 beta-oestradiol in vitro. Br. J. Pharmacol., 10, 1033-1037.
28. JIANG, C.W., SARREL, P.M., LINDSAY, D.C., POOLE-WILSON, P.A. & COLLINS, P. (1992). Progesterone induces endothelium-independent relaxation of rabbit coronary artery in vitro. Eur. J. Pharmacol., 21, 163-167.
29. JINSI, A. & DETH, R.C. (1995). Alpha 2-adrenoceptor-mediated vasoconstriction requires a tyrosine kinase. Eur. J. Pharmacol., 27,29-34.
30. KARAS, R.H., PATTERSON, B.L. & MENDELSOHN, M.E. (1994). Human vascular smooth-muscle cells contain functional estrogen-receptor. Circulation, 89, 1943-1950.
31. KITAZAWA, T., HAMADA, E., KITAZAWA, K. & GAZNABI, A.K. (1997). Non-genomic mechanism of 17 beta-oestradiol-induced inhibition of contraction in mammalian vascular smooth muscle. J. Physiol., 49,497-511.
32. KUSHWAHA, R.S. & HAZZARD, W.R. (1981). Exogenous estrogens attenuate dietary hypercholestrolemia and atherosclerosis in the rabbit. Metabolism. 30, 359-366.
33. LANIYONU, A.A., SAIFEDDINE, M., YANG, S.G. & HOLLENBERG, M.D. (1994). Tyrosine kinase inhibitors and the contractile action of G-protein- linked vascular agonists. Can. J. Physiol. Pharmacol., 72, 1075-1085.
34. LARSON, B., ANDERSON, K.E., BATRA, S., MAITTIASSON, A. &. SJOGREN, C. (1984). Effects of estradiol on norepinephrineinduced contraction, alpha-adrenocepto number and norepinephrine-content in the female rabbit aorta. J. Pharmacol. Exp. Ther., 21, 615-618.
35. LOSORDO, D.W., KEARNEY, M., KIM, E.A., JEKANOWSKI, J. & ISNER, J.M. (1994). Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation, 89, 1501-1510.
36. LUDMER, P.L., SELWYN, A.P., SHOOK, T.L., WAYNE, R.R., MUDGE, G.H., ALEXANDER, R.W. & GANZ, P. (1986). Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. New Eng. J. Med., 31, 1046-1051.
37. MADDOX, Y.T., FALCON, J.G., RIDINGER, M., CUNARD, C.M. & RAM WELL, P.W. (1987). Endothelium-dependent gender differences in the response of the rat aorta. J. Pharmacol. Exp. Ther., 24, 392-395.
38. MAGNESS, R.R., SHAW, C.E., PHERNETTON, T.M., ZHENG, J. & BIRD, I.M. (1997). Endothelial vasodilator production by uterine and systemic arteries. II. Pregnancy effects on NO synthase expression. Am. J. Physiol., 27, H1730-H1740.
39. MEYER, M.C., CUMMINGS, K. & OSOL, G. (1997). Estrogen replacement attenuates resistance artery adrenergic sensitivity via endothelial vasodilators. Am. J. Physiol., 27, H2264H2270.
40. MILLER, V.M. & VANHOUTTE, P.M. (1990). 17 beta-Estradiol augments endothelium-dependent contractions to arachidonic acid in rabbit aorta. Am. J. Physiol., 25, R1502-R1507.
41. MUGGE, A., RIEDEL, M., BARTON, M., KÜHN, M. & LICHTLEN, P.R. (1993). Endothelium independent relaxation of human coronary arteries by 17 beta-oestradiol in vitro. Cardio. Res., 27, 19391942.
42. MYERS, S.I., TURNAGE, R.H., BARTULA, L., KALLEY, B. & MENG, Y. (1996). Estrogen increases male rat aortic endothelial cell (RAEC) PGI2 release. Prostaglandin. Leukou. Ess. Fat. Acid., 54, 403-409.
43. OPEI, L.H. & SINGH, B.N. (1987). Calcium channel antagonists (slow channel blockers). In Drugs for the heart. 2nd ed. ed. Opei, H.L. pp 34-55. Orlando: Grune and Stratton.
44. PALMER, R.M.J., FERRIGE, A.G. & MONCADA, S. (1987). Nitric oxide release accounts for the biological activity of endotheliumderived relaxing factor. Nature, 32, 524-526.
45. PAREDES-CARBAJAL, M.C., JUAREZ-OROPEZA, M.A., ORTIZ-MENDOZA, C.M. & MASCHER, D. (1995). Effects of acute and chronic estrogenic treatment on vasomotor responses of aortic rings from ovariectomized rats. Life Sei., 57, 473-486.
46. PIETRAS, R.J. & SEZEGO, C.M. (1979). Estrogen receptors in uterine plasma membrane. J. Sterod. Biochem. Mol. Biol., 19, 730-736.
47. REES, D.D., PALMER, R.M.J. & MONCADA, S. (1989). Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc. Natl. Acad. Sei. U.S.A., 86, 3375-3378.
48. REIS, S.E., GOLTH, S.T., BLUMNETHAL, R.S., RESAR, J.R., ZACUR, H.A., GERSTENBLITH, G. & BRINKER, J.A. (1994). Ethyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postemenopausal women. Circulation, 89, 52-60.
49. SALAS, E., LOFEZ, M.G., VILLARROYA, M., SANCHEZ-GARCIA, P., DE PASCUAL, R., DIXON, W.R. & GARCIA, A.G. (1994). Endothelium-independent relaxation by 17-alpha-estradiol of pig coronary arteries. Eur. J. Phannacol., 25, 47-55.
50. SAURO, M.D., SUDAKOW, R. & BURNS, S. (1996). In vivo effects of angiotensin II on vascular smooth muscle contraction and blood pressure are mediated through a protein tyrosine-kinasedependent mechanism. J. Phannacol. Exp. Ther., 27, 17441750.
51. STAMPER, M.J., COLDITZ, G.A., WILLEET, W.C., MANSON, J.E., ROSNER, B., SEIZER, F.E. & HENNEKENS, C.H. (1991). Postmenopausal estrogen therapy and cardiovascular diseases. Ten year follow-up from the Nurses' Health Study. N. Engl. J. Med., 32,756-762.
52. 2+ uptake of uterine arterial smooth muscle cells through potential-sensitive channels. Biol. Reprod., 36, 361 -368.
53. SULISTIYANI, S.J., ADELMAN, J.S., CHANDRASEKARAN, A., RAYO, J. & ST. CLAI R, R.W. (1995). Effects of 17-x-dihydroequilin sulfate, a conjugated equine estrogen and ethylestradiol on atherosclerosis in the rabbit. Alherioscler. Thromb. Vase. Biol., 15,837-846.
54. SULLIVAN, J.M., VANDER ZWAAG, R., LEMP, G.F., HUGHES, J.P., MADDOCK, V., KROETZ, F.W., RAMANATHAN, K.B. & MIRVIS, D.M. (1988). Postmenopausal estrogen use and coronary atherosclerosis. Ann. Intern. Med., 10, 358-363.
55. THOMAS, G., ITO, K., ZIKIC, E., BHATTI, T., HAN, C. & RAMWELL, P.W. (1995). Specific inhibition of the contraction of the rat aorta by estradiol 17 beta. J. Phannacol. Exp. Ther., 27, 1544-1550.
56. TOMA, C, JENSEN, P.E., PRIETO, D., HUGHES, A., MULVANY, M.J. & AALKJAER, C. (1995). Effects of tyrosine kinase inhibitors on the contractility of rat mesenteric resistance arteries. Br. J. Phannacol., 11, 1266-1272.
57. VARGAS, R., THOMAS, G., WROBLEWSKA, B. & RAMWELL, P.W. (1989). Differential effects of 17 alpha and 17 beta estradiol on PGF2 alpha mediated contraction of the porcine coronary artery. Adv. Prostaglandin. Tliromboxane. Leuko. Res., 19, 277-280.
58. VEDERNIKOV, Y.P., LIAO, Q.P., JAIN, V., SAADE, G.R., CHWALISZ, K. & GARFIELD, R.E. (1997). Effect of chronic treatment with 17 beta-estradiol and progesterone on endothelium-dependent and endothelium-independent relaxation in isolated aortic rings from ovariectomized rats. Am. J. Obst. Gynecol., 17, 603-608.
59. VITA, J.A., TREASURE, C.B. & NABEL, E.G. (1990). Coronary vasomotor response to acetylcholine relates to risk factors for coronary arteries. Circulation, 81, 491-497.
60. WALSH, B.W., SHIFF, L, ROSNER, B., BREENBERG, L., RAVNIKAR, V. & SACKS, P.M. (1991). Effects of postmenopausal estrogen replacement therapy on the concentration and metabolism of plasma lipoproteins. N. Engl. Med., 32, 1196-1204.
61. WEINER, C.P., LIZASOAIN, I., BAYLIS, S.A., KNOWLES, R.G., CHARLES, I.G. & MONCADA, S. (1994). Induction of calciumdependent nitric oxide synthases by sex hormones. Pro. Nat. Acad. Sei. U.S.A., 91, 5212-5216.
62. + channels. Cir. Res., 79, 1024-1030.
63. WILLIAMS, J.K., ADAMS, M.R., HERRINGTON, D.M. & CLARKSON, T.B. (1992). Acute administration of estrogen and vascular responses of atherosclerotic coronary arteries. J. Am. Col. Cardiol., 20, 452-457.
64. WILLIAMS, J.K., ADAMS, M.R. & KLOPFENSTEIN, H.S. (1990). Estrogen modulates responses of atherosclerotic coronary arteries. Circulation, 81, 1680-1687.
65. WILLIAMS, J.K., KIM, Y.D., ADAMS, M.R., CHEN, M-F., MYERS, A.K. & RAMWELL, P.W. (1994). Effects of estrogen on cardiovascular responses of premenopausal monkeys. J. Pliarmacol. Exp. Ther.. 27, 671-676.
66. WINGROVE, C.S. & STEVENSON, J.C. (1997). 17-/J-estradiol inhibits stimulated endothelin release in human vascular endothelial cells. Eur. J. Endocrinol.. 13, 205-208.
67. YOUSIF, M.H., OR1OWO, M.A. & WILLIAMS, K.I. (1997). Evidence for tyrosine kinase involvement in noradrenaline-induced vasoconstriction of the rabbit perfused ovarian vascular bed. Br. J. Pharmacol., 12, 190.
68. 2+ currents in A7r5 vascular smooth muscle cell line. Ain. J. Physiol.. 26, C975-C980.